BETH ISRAEL DEACONESS MEDICAL CENTER, INC.;FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT.
发明人:
Rupal BHATT
申请号：
US16609386
公开号：
US20200188473A1
申请日:
2018.05.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention features compositions comprising a tyrosine kinase inhibitor and an agent that enhances Ang1-7 levels, and methods of using such compositions for the treatment of neoplasias (e.g., metastatic renal cell carcinoma).
